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Chikungunya is an arbovirus, belonging to the 
alphavirus family of bunyaviridae. It was first 
documented in Tanzania in 1953. Since then 
it has been reported from Europe (France and 
Italy), Africa (Madagascar, Kenya), Americas 
(United States, Mexico, and all of South America) 
and Asia (India, Sri Lanka, China, Malaysia, 
Thailand, Cambodia, and Yemen). Recently there 
has been an outbreak in Malir district of Karachi, 
Pakistan. 
Due to its main symptom of severe joint pain, it was 
named chikungunya, meaning “that which bends 
up”. Other symptoms include muscle pain, headache 
and rash is usually maculopapular, after the onset of 
fever. 
Usually the disease is self-limiting and patient 
feels better within a week’s time. However in some 
people joint pain may persist for several months. 
Certain people are at higher risk of severe disease 
with neurological or cardiac complications, like 
newborns or elderly, and those who have underlying 
comorbids, like heart disease, hypertension and 
diabetes.
Transmission
Chikungunya is transmitted to humans by the 
mosquito species Aedes aegypti and A. albopictus. 
Both mosquitoes have white strips on black bodies and 
legs and will be biting at any time of the day. Aedes 
mosquito is also responsible for dengue infection.
Diagnosis
l  Serology: this diagnostic test includes the 
  detection of IgM and IgG. These tests can 
  be performed on serum or plasma using 
  enzyme-linked immunosorbent assay (ELISA), 
  indirect immunofluorescence, hemagglutination 
  inhibition, or neutralization techniques.
Chikungunya
From the Editor’s Desk
Ms Najma Shaheen
Clinical Microbiology
LABRAD in 2017 begins on a thematic note. Our 
focus this time is “Infectious Diseases”. Diagnostic 
modalities play a central role in the therapy of 
infectious diseases. With advancing technology, 
the main focus remains on rapid turnaround times. 
Diagnostic tests especially in our population should 
be performed cost effectively with rapid delivery 
of results in order to institute timely treatment. 
In some infections, early diagnosis and treatment 
prevent long-term complications or break the 
continuity of transmission of the infectious agent. In 
particular, diagnostic tests should come in handier 
when clinical symptoms are not specific for a 
particular infection (which occurs quite commonly). 
Apart from this, testing for asymptomatic 
infections, surveillance for hospital acquired 
infections, evaluating response to treatment, and 
detecting infections common to the developing 
world are pre-requisites for any diagnostic test 
employed for Infectious disease testing in Pakistan. 
In this issue, we have covered topics which include 
Chikungunya, Rubella, common bone and soft 
tissue infections, Epstein Barr virus infection and 
H.pylori to name a few. We have also added an 
interesting quiz for our readers. Hope you will 
enjoy the material and gain new insights in this 
particular field of Medicine.                                         
Dr Natasha Ali
Editor, LABRAD
Figure 1: Aedes aegypti (left) and A. albopictus (right) (Courtesy: 
Google Images)
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  IgM can be detected after the five days of 
  infection and it remains detectable up to 
  three months. The IgG antibodies can be 
  detected in convalescent samples (Figure 2) and 
  persist for years. The serologic tests are widely 
  used because they are more cost-effective than 
  other diagnostic tests in terms of disease 
  detection. They are also easy to perform. It may 
  show cross-reactivity with other alphaviruses 
  and minimally with flaviviruses like dengue.
l  Culture:  Viral culture can detect virus within  
  three days of illness. However,  it requires 
  skilled personnel and well-equipped facilities 
  which may not be available everywhere.
l  Molecular diagnosis: RT-PCR consider as the 
  rapid diagnosis for Chikungunya infection as it 
  can detect viral RNA in blood as early as five 
  days after the symptoms appear. However, it 
  will not detect the virus efficiently after five 
  days of disease onset.
Testing of Chikungunya IgM by Elisa Method at 
AKU
Chikungunya IgM Ab has been initiated in Clinical 
Microbiology lab by ELISA method. This test is 
performed twice a week. 
Treatment and Prevention
l  Good intake of fluid, taking rest and pain killers  
  are the only treatment.
l  Vaccination is not available as yet.
l  Vector control is the main public health     
  strategy. Draining stagnant water and keeping 
  stored water covered will deplete the main 
  sites of mosquito breeding. Mosquito coils, bed 
  nets and mosquito repellents should be used to 
  avoid mosquito bites. Figure 2: Contribution of PCR and blood tests on the diagnosis of Chikungunya, according to delay after test. 2
Character
Causative agent
Vector
Incubation period
Disease duration
Symptoms
Hemorrhage and shock
Laboratory findings
 
Complications
Dengue
Dengue virus, (Flavivirus of Flaviviridea family)
Aedes aegypti, A. albopictus
4-7 days
4-7 weeks
Fever, backache, large joint pain, headache, rash 
usually on face and limbs, retro-orbital pain. No 
arthritis
Common in Dengue Haemorrhagic Fever  (DHF) 
and Shock Syndrome (DSS)
Thrombocytopenia (<100,000/mm3), lymphopenia, 
and neutropenia. Elevated liver enzymes (ALT, 
AST); more with DHF
Life threatening complications such as shock, 
ARDS, multi-organ failure and severe haemorrhage
Chikungunya
Chikungunya virus (alphavirus of Togaviridea 
family)
Aedes albopictus, A. aegypti
3-7days (range 1-12 days)
1-2 weeks, arthralgia may last for months
Fever, arthritis, pain in all joints, more promi-
nent in small joints (worse in the morning), 
headache, eye pain, generalized rash
Rare
Mild thrombocytopenia (>100,000/ mm3), 
lymphopenia, elevated liver enzymes (ALT, 
AST)
 
Upto 10% develop chronic joint pain.  Rarely 
neuroinvasive disease
Difference between Chikungunya and Dengue 
Virus:1
References:
1. Microbiology notes by Pratiksha Pokhrei, updated on 31st March 2016. Last accessed 21st Jan 2017. http://www.microbiologynotes.com/differences-between-dengue-and-
chikungunya/ 
2. Simon F. et al. French guidelines for the management of chikungunya (acute and persistent presentations). November 2014. Médecine et maladies infectieuses 45 (2015) 
243–263
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Rapid Molecular Diagnosis of Chlamydia 
Trachomatis (CT) and Neisseria Gonorrhoeae 
(NG) Urethritis 
Ms Najma Shaheen
Clinical Microbiology
Among the list of microorganisms involved in 
sexually transmitted diseases, Chlamydia trachomatis 
(CT) and Neisseria gonorrhoeae (NG) are the 
most prevalent. Every year both CT and NG cause 
around 351.7 million cases of human infection1, 
associated with long term complications in both men 
and women especially pregnant women and their 
children. The complications include fetal growth 
retardation, preterm birth, low birth weight, pelvic 
inflammatory disease (PID) or ectopic pregnancy 
and infertility. It can also cause perinatal diseases 
such as conjunctivitis and pneumonia and sometimes 
even infant death. For mothers who have been 
infected with CT and NG there is also high incidence 
of vertical transmission of HIV from mother to 
children.
Neisseria Gonorrhoeae (NG)/Chlamydia 
Trachomatis (CT) Diagnosis
l Microscopy 
Microscopic 
examination 
of urethral, 
endocervical         
swabs and 
secretions is a 
rapid test for 
the detection of 
NG in which 
they appear 
as intracellular 
gram negative bean shaped diplococci. Due to 
lack of specificity, gram stain is not recommended 
by the CDC for the detection of GC infection in 
asymptomatic men and women at any site other than 
the urethra.  
Chlamydiae are non-motile bacteria that are located 
intracellularly and require giemsa stain for their 
detection. Giemsa stain is difficult to interpret and 
requires skilled personnel, and therefore is not 
readily available at all laboratories for chlamydia.
l Culture
Culture can be relatively inexpensive and is highly 
specific, but <100% sensitive when applied in 
routine clinical practice due to the fastidiousness 
of the  Neisseria gonorrhoeae, which makes 
successful growth less likely if isolation methods, 
media, specimen transport are not optimal. Another 
disadvantage is that a minimum of 72 hours is 
required from specimen collection to the report of a 
presumptive culture.
Specimens that can be used for the detection of 
CT include endocervical swab, urethral swab, and 
female genital tract tissue collected during surgery. 
Culture has been the gold standard for Chlamydia in 
the past, but there are difficulties in maintaining the 
viability of organisms during transport and storage in 
the diverse settings. Therefore, non-culture tests are 
being used in diagnostic clinical laboratories. 
The non-culture tests for C. trachomatis and N. 
gonorrhoeae include 
 —  Enzyme immunoassays (EIAs)
 —  Direct fluorescent antibody (DFA) tests
 — Nucleic acid amplification testing (NAAT)
Despite culture being the gold standard, the 
performance of Nucleic Acid Amplification Test 
(NAAT) is overall better because its sensitivity and 
specificity is higher for both CT and NG.
Rapid testing of CT/NG by Gene Xpert 
introduced at AKU
l Technique: This assay is a rapid real-time PCR 
 nucleic acid amplification test. The cartridge- 
 based assay detects DNA of Chlamydia 
 trachomatis and Neisseria gonorrhoeae.
l Turnaround time (TAT): This test has been 
 introduced in Clinical Microbiology Laboratory 
 at Aga Khan University Hospital. At this point 
 only urine samples are tested for CT/NG, while  
Intracellular gram negative diplococci. 
Courtesy Google Images
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 testing on vaginal and endocervical specimens 
 will be started later. Results are available within 
 90 minutes and it is performed 24 hours every 
 day. It may be used as a point of care test if  
 installed in clinics.  
Samples Required for Testing
l First-catch Urine for both males and females: 
 Unpreserved (neat) urine or collected using 
 the Urine Specimen Collection Kit provided by 
 manufacturer may be used 
l Endocervical /Vaginal swab specimens: Only 
 the manufacturer-provided Vaginal/ Endocervical 
 Specimen Collection Kit can be used for these 
 specimens, as it preserves patient specimens 
 during transport to the laboratory. 
Figure 1: Courtesy: Google Images
Rubella is a member of togaviridae family and 
humans remain the only natural host for this 
virus. Rubella is also known as German measles 
occurring throughout the world. Transmission 
is typically through inhalation of infectious 
aerosolized respiratory droplets and the incubation 
period following exposure can range from 12 to 
23 days. The prodromal stage includes malaise 
and a low grade fever followed by characteristics 
of lymphadenitis and finally a macular or 
maculopapular rash. Primary infection during 
pregnancy can pass transplacentally to the fetus 
and can lead to fetal death or Congenital Rubella 
Syndrome (CRS). Babies born with CRS typically 
exhibit low birth weight, deafness, eye disease, 
mental retardation and cardiac abnormalities. Rubella 
infections are frequently mild or non-specific, making 
the infection difficult to diagnose clinically. For these 
reasons, pregnant women with an undiagnosed illness 
with rash should be evaluated for the possibility of an 
acute primary rubella infection. While the virus can be 
cultured in vitro, serology remains the principal means 
for establishing a clinical diagnose of acquired rubella 
and congenital infections.
Interpretation of Rubella antibodies Positive 
results
A primary infection induces an IgM and IgG 
response. Within four to six months, IgM levels 
becomes undetectable or very low. IgG decreases to 
low levels but lasts indefinitely and confers lifelong 
immunity. The secondary infection exhibits a rising 
IgG antibody without significant levels of IgM.
Rubella IgM Positive
Immunoglobin IgM serological testing is the primary 
diagnostic test use to confirm acute rubella infection. 
An IgM test should not be used to determine rubella 
immune status; IgM is used to diagnose acute and 
recent rubella infection.  Rubella IgM testing should 
be performed on pregnant women who report 
symptoms of rubella or susceptible pregnant women 
who might have been exposed to rubella to rule out 
acute or recent infection.
Rubella IgG positive
A positive rubella IgG antibody test indicates 
rubella immunity (in pregnant females or vaccinated 
children). However the presence of rubella IgG in an 
infant after the decline of maternal antibodies (nine 
months of age) and the absence of vaccination or 
exposure to rubella will confirm CRS. Rubella IgG 
antibody avidity can be used to distinguish between 
recent infection and remote rubella infection, IgG 
increases with time; this is known as maturation of 
the immune response.
Overview of Rubella Testing
Iffat Arman
Section of Chemical Pathology
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Sepsis refers to the presence of a serious infection 
that correlates with systemic and uncontrolled 
immune activation. To date no gold standard test 
is recognized for diagnosis of sepsis however 
microbiological culture is taken as a reference 
standard. Prompt diagnosis of sepsis is challenging, 
with turnaround times surpassing the limits for rapid 
diagnosis because microbiological culture results 
take several days to come up so it is common clinical 
practice to utilize available biomarkers that offer 
rapid kinetics leading to an improved patient care 
and facilitation. The various tests that are offered by 
our clinical laboratory include:
Serum C - reactive protein (CRP)
CRP is a protein produced in response to infection 
and it is extensively utilized in clinical practice to 
diagnose and manage patients with sepsis. It is a 
positive acute phase reactant whose synthesis in 
the liver is up regulated by IL-6. The mechanism 
of action in acute inflammation is that it may bind 
the phospholipid components of microorganisms, 
facilitating their removal by macrophages. Even 
though its low specificity may be its primary 
disadvantage as a biomarker of sepsis in adults, it is 
commonly used to screen for early onset sepsis in 
pediatrics. Normal concentration in healthy human 
serum is usually lower than 10 mg/L whereas in 
mild inflammation and viral infections it rises to 
10–40 mg/L. Levels in active inflammation, bacterial 
infection are in range of  40- 200 mg/L. Whereas in 
severe bacterial infections and burns  levels >200 
mg/L have been recorded.
Serum Procalcitonin (PCT)
Procalcitonin is a pro hormone (peptide precursor) 
of calcitonin that is secreted by parenchymal 
cells, including hepatocytes, renal parenchymal 
cells, adipocytes, and muscle cells in response to 
bacterial toxins. Procalcitonin has also been used 
to distinguish fungal and viral infections from 
bacterial infections. During viral infections, PCT 
levels are reported to remain at low levels, often 
at concentrations found in healthy individuals. It 
follows a rapid kinetics with levels rising in two 
to four hours in response to bacterial infection. On 
the other hand its level doesn’t show abrupt rise in 
patients with viral infections. It possesses a half-life 
of 22 to 26 hours, making it a superior marker in 
term of kinetics compared with CRP and other acute-
phase reactants. However it faces certain limitation 
that includes possible elevation in noninfectious 
disorders, especially following trauma.
Furthermore PCT levels have been extensively used 
to guide empirical antibacterial therapy in patients 
with acute exacerbations of chronic bronchitis, 
community-acquired pneumonia, and sepsis. PCT 
also serves as a prognostic marker of sepsis as 
PCT levels have been found to be associated with 
increased mortality rates and correlate well with 
severity scores (APACHE, SOFA, and SAPS). The 
rapid elevation and sustainment of PCT levels in the 
serum during infection makes it an ideal biomarker. 
As a biomarker for bacterial infection, most studies 
find PCT to be a useful and accurate biomarker.
Plasma Lactate
Hyper-lactatemia is characteristically present in 
patients with severe sepsis or septic shock and may 
be ancillary to anaerobic metabolism owing to hypo 
perfusion or other multifaceted factors. The prognostic 
value of elevated blood lactate levels has been well 
recognized in septic shock patients, particularly if the 
high levels continue. Given the high risk for septic 
shock, all patients with elevated lactate >4 mmol/L 
(36 mg/dL) are considered the early goal-directed 
therapy zone irrespective of blood pressure. Mortality 
is high in septic patients with lactate ≥4 mmol/L 
making it a worthy prognostic marker as well.
Conclusion 
Serum biomarkers discussed here have the potential 
to diagnose, monitor, stratify and predict outcome in 
sepsis. C-reactive protein is elevated in inflammatory 
and infectious conditions and has long been used as a 
biomarker indicating infection. Procalcitonin has more 
recently been shown to better distinguish infection 
from inflammation. Another important biomarker that 
has specific relevance to distinguishing sepsis from 
septic shock and predicting the prognosis of the latter 
is the lactate level.
Biomarkers for Sepsis
Dr Sibtain Ahmed
Chemical Pathology
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Tuberculous Osteomyelitis
Tuberculous osteomyelitis is one of the most 
common causes of bone infection seen in our 
practice. The usual source of origin is from foci of 
active visceral disease that are in the initial stages 
of primary infection. The spine is affected in 40-
50 per cent of cases of tuberculous osteomyelitis, 
and is followed in frequency by the hip and knee 
joint bones in 25 per cent and 20 per cent of cases, 
respectively. In the spine, 98 per cent of infections 
are centered in the anterior column and the involved 
level is usually located in the region of T6-L3, 
leading to the formation of a gibbus or kyphosis. 
The histologic features consist of the presence of 
granulomas composed of aggregates of epithelioid 
macrophages admixed with multinucleated giant 
cells including Langhans type giant cells (Figure 
1). Areas of caseous necrosis within a variably 
inflammatory and frequently necrotizing background 
are often seen. Acid-fast bacilli which are typically 
beaded and bent and most often found either in the 
necrotic zone or in the giant cells, but can be seen 
anywhere in the granulomatous deposit on ZN stain. 
 
Parasitic Osteomyelitis
Human echinococcal infection occurs across the 
globe. It is more common in our population and 
results from the ingestion of contaminated water and 
food or handling live animals which act as definitive 
hosts such as dogs, or working with their pelts. 
The swallowed eggs hatch in the small intestine 
Figure 1: Granulomatous inflammation of bone with necrotizing 
granulomas formation
Most Common Bone and Soft Tissue 
Infections Seen in our Practice
Dr Nasir Ud Din and Dr Muhammad Usman Tariq
Histopathology 
Introduction
Soft tissue and bone infections can be caused 
by either direct penetration of a pathogen or by 
hematogeneous spread of the pathogen from the 
initial site. In this article we shall discuss common 
bone and soft tissue infections seen in our practice.
Bacterial Infection of Bone
The most common form of infection of bone 
(pyogenic osteomyelitis) is caused by hematogenous 
spread of bacterial infection elsewhere in the body 
such as a urinary tract infection or pneumonia. 
Osteomyelitis also occurs after surgery, bone fracture 
after road traffic accident and open wound over 
bone in diabetics. In the initial stages of infection, 
bacteria multiply, setting up a localized inflammatory 
reaction and resulting in localized cell death. With 
time, the infection becomes demarcated by a rim of 
granulation tissue and new bone deposition.
Although no organisms are recovered in up to 50 per 
cent of cases, when one is isolated, Staphylococcus 
aureus is by far the most common agent accounting 
for 80-90 per cent of all infections. Escherichia coli, 
Klebsiella and Pseudomonas species are associated 
with osteomyelitis in intravenous drug users and 
genitourinary tract infection. Salmonella is involved 
in osteomyelitis of patients with sickle cell disease. 
Haemophilus influenza and group B streptococci are 
involved in osteomyelitis of neonates.
In children, osteomyelitis usually affects the long 
bones of extremities, including the femur and 
humerus. Adults usually develop osteomyelitis 
of vertebrae, fractured long bones and at hip 
replacement. Osteomyelitis initially develops rapidly 
and is usually accompanied by pain, fever, and joint 
stiffness. Chronic osteomyelitis progresses slowly 
and may be the result of a previous bone infection. 
The histologic features of chronic infection also 
include infarction of the bone with bony sclerosis, 
as well as a mixture of inflammatory cells consisting 
of macrophages, lymphocytes, plasma cells, and 
neutrophils. 
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and release minute hooked embryos which burrow 
through the bowel wall and are then transported by 
the bloodstream to various sites such as the lung, 
liver, brain, skeletal muscle, and eyes. Involvement 
of the skeletal system is rare and occurs in 0.2-4 per 
cent of cases. Once the organisms reach their final 
destination, they produce hydatid larval cysts. These 
unilocular cysts are filled with fluid and lined by 
an inner germinal membrane that produces brood 
capsules (Figure 2). The inner wall of the brood 
capsules facilitates an asexual budding process 
that generates thousands of new larval tapeworms 
(protoscolices) in daughter cysts. The hydatid cysts 
can achieve large size (2 to 30 cm), have a thick wall 
and contain clear or pale yellow fluid. The sites of 
bone disease commonly include the spine, pelvis and 
long bones. Once lodged within bone the hydatid 
cyst fills the spaces between the bony trabeculae 
and eventually results in their resorption and that of 
the neighboring cortex such that it extends into the 
adjacent soft tissues. 
Mycetoma (named because of the tumour-like 
mass it forms) is a chronic granulomatous 
disease predominantly involving feet (hence 
also named Madura foot) and rarely can involve 
the hands, back or shoulders. It is characterized 
by localized infection of cutaneous and 
subcutaneous tissues by actinomycetes or 
fungi. Approximately 40 per cent of mycetomas 
worldwide are eumycotic as opposed to 
actinomycotic (i.e, caused by bacterial 
actinomycetes). The disease is marked by 
progressive destruction of soft tissue and nearby 
anatomic structures.
Mode of infection is an inoculation of the 
causative microorganism via small injuries of 
the skin. The clinical correlate of both forms 
of mycetoma is tumescence with abscesses, 
painless nodules, sinuses and discharge. The 
latter is commonly serous-purulent and contains 
grains (filamentous granules) which can be 
expressed for diagnostic purposes. Distinctive 
for both eumycetoma and actinomycetoma, 
are the formation of grains. Grains represent 
microcolonies of the microorganism in vivo 
in the vital tissue. Differentiation between 
actinomycetoma and eumycetoma is important 
because they respond to different treatments. 
The diagnosis can be established only by 
finding the “sulfar granules”. The granules of 
both eumycetoma and actinomycetoma stain 
with PAS and silver stain; those of eumycetoma 
are composed of septate hyphae (4-5 µm), 
whereas granules of actinomycetoma usually 
consists of fine, branching filaments of bacillary 
Figure 2: Hydatid cyst of bone. The acellular lamellated membranes are 
filling the intertrabecular areas.
Eumycetoma (Fungal mycetoma)
Figure 3: Fungal mycetoma. There is massive tissue reaction with epi-
thelioid cell granulomas together with grain which is a conglomerate of 
septated and branched hyphae. Staining: PAS (Periodic-acid-Schiff) with 
diastase reaction.
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forms (1 µm). Filaments of actinomycetoma are 
gram positive, whereas the hyphae in grains of 
eumycetoma are gram negative.
Fungal Osteomyelitis
Fungal osteomyelitis may occur as a component 
of a multisystem infection or as an isolated 
condition. It may evolve slowly and masquerade 
other conditions such as tuberculosis, myeloma, 
and metastatic disease. Fungal osteomyelitis 
is a serious illness and is most virulent in 
immunodeficient patients. Bone infection 
occurs by hematogenous dissemination, direct 
inoculation, and spread from a neighboring site 
of disease. The clinical presentation and outcome 
varies according to the specific pathogen, location 
of the infection, and host factors. Invariably the 
infection causes pain, localized swelling, bone 
destruction with reactive changes, and a prominent 
inflammatory reaction. Definitive diagnosis 
usually requires identification of the organism in 
tissue specimens or cultures (Figure 4). Figure  4: Fungal infection of bone. Numerous branching hyphae are 
present in necrotic background which is positive for PASD stain.
PASD
Epstein-Barr virus (EBV), also known as human 
herpesvirus four is a member of the herpes virus 
group and is the etiologic agent of infectious 
mononucleosis. Other disorders due to EBV 
infection include Burkitt lymphoma, nasopharyngeal 
carcinoma and lymphoproliferative syndromes 
especially in patients who have undergone renal or 
bone marrow transplantation or those with AIDS. 
Most people have been exposed to EBV by early 
adulthood. Many people become infected with EBV 
in childhood. EBV infections in children usually 
do not cause symptoms, or the symptoms are not 
distinguishable from other mild, brief childhood 
illnesses. People, who get symptoms from EBV 
infection, usually teenagers or adults, get better 
in two to four weeks. However, some people may 
feel fatigued for several weeks or even months. 
Symptoms of EBV infection can include fever, 
inflamed throat, swollen lymph nodes in the neck, 
enlarged spleen, inflamed liver or rash. After you get 
Overview of Epstein - Barr Virus Antibodies 
Panel
Dr Tayyaba Hassan
Chemical Pathology
an EBV infection, the virus becomes latent (inactive) 
in your body. In some cases, the virus may reactivate. 
This does not always cause symptoms, but people 
with weakened immune systems are more likely 
to develop symptoms if EBV reactivates. EBV is 
difficult to diagnose using one serological assay. 
The EBV virus is composed of a double helix 
of DNA. The DNA is surrounded by a protein 
nucleocapsid (Figure 1). This nucleocapsid is 
surrounded by a tegument made of protein, which in 
turn is surrounded by an envelope containing both 
lipids and surface projections of glycoproteins which 
are essential to infection of the host cell. 
Envelope protein
Envelope
Viral genome
Nucleocapsid
Viral tegument
Figure 1: EBV structure
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Table 1: Interpretation of EBV antibody profile
No previous exposure
Early primary infections
Acute infection
Past infection
Recovery stage
EBNA-IgG
Negative
Negative
Negative
Positive
Positive
Diagnosis of an acute/ recurrent infection is best 
accomplished by using a profile or panel of assays 
which has three components: 
• IgG Viral capsid antigen (VCA)
• IgM VCA
• IgG Epstein Barr nuclear antigen (EBNA )
The presence of VCA IgG antibodies indicates infection 
sometime in the past. Antibodies to EBNA develop six 
to eight weeks after primary infection and are detectable 
for life. Specimens drawn too early during the course 
of the disease may not contain detectable antibody to 
Epstein-Barr virus (EBV). Another specimen drawn 
one to two weeks later may be required.
VCA-IgM
Negative
Positive
Positive
Negative
Positive
VCA-IgG
Negative
Negative
Positive
Positive
Positive
Diagnosis of Helicobacter Pylori Infection in 
Developing Countries- Pros & Cons
Ms Syeda Kiran Zaidi
Clinical Microbiology
Helicobacter pylori infection is now recognized as 
a worldwide problem. It is the most common cause 
of chronic gastritis, peptic ulcer and it can also lead 
to gastric cancer. Like all developing countries, 
Pakistan also has high H. pylori prevalence, >85 
percent (1). The most common route of H.pylori 
infection is fecal- oral. Mostly, patients infected 
with H.pylori are asymptomatic. When signs 
and/or symptoms are present, they may include 
nausea, vomiting, abdominal pain, heartburn, 
diarrhea, hunger pangs in the morning, and halitosis 
(bad breath). Diagnosis of H.pylori infection is 
divided into two subgroups i.e. invasive and non-
invasive tests.  Invasive tests include endoscopy, 
histopathology, culturing from tissue and rapid 
urease test, whereas non-invasive tests include 
stool antigen test, antibody response as a marker of 
disease, and urea breath test. 
Non-Invasive Tests
Stool antigen test detects active H.pylori infection, 
independent of age, and has high sensitivity 
and specificity; whereas, Anti-H. pylori IgG is a 
supportive test as antibody titers remain high for 
months or years even after treatment (Table 1). 
For optimal results of stool antigen test, the patient 
should be off antacids and proton pump inhibitors 
(PPIs) for at least two weeks. Serological testing is 
relatively inexpensive and it is widely available. In 
a low-prevalence area a negative test has more value 
than a positive test while in a high-prevalence area, 
positive serology can reasonably be accepted as 
positive. Urease breath test is also used as a common 
non-invasive test; it is highly sensitive and specific. 
One of the limitations is the presence of other 
urease producing bacteria in the stomach, e.g. H. 
heilmannii, which might lead to false positive results. 
Moreover, acute bleeding and co-medication can lead 
to false negative test results.
Invasive Tests
Among invasive test for H. pylori endoscopic biopsy 
for histology remains the gold standard and has 
a sensitivity of 95 percent and specificity of 100 
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percent but sensitivity may be reduced by the use of 
PPIs, antibiotics, bismuth containing compounds and 
test is also time-consuming and difficult to obtain.
H.pylori culture is not a routine procedure because 
isolation of this microaerophilic organism from 
gastric biopsy specimens takes five–seven days 
and has an extremely low yield. Rapid urease test 
on antral biopsy provide a simple, rapid, and cost-
effective method for the detection of H. pylori. 
However, the value of these tests depends not only 
on performance, but also on rapidity, making them a 
practical tool for the endoscopist in decision-making 
as to whether or not therapy should be prescribed. 
False negative results can occur in patients taking 
antisecretory drugs.
H. pylori seen on H&E. Image courtesy 
http://www.pathologyoutlines.com/caseofweek/case157.htm
Alert: WHO has identified Helicobacter pylori 
as one of the 12 priority organisms (Priority 2 
HIGH) for anti-microbial resistance, i.e. resistant 
to clarithromycin
Table 1: Comparison of diagnostic tests for Helicobacter pylori infection 
Test
Stool 
Antigen test
Serology 
(IgG Ab)
Urea Breath test 
Biopsy
Culture
Rapid 
Urease test
Sensitivity
96%
85-92%
95%
>95%
~30-40%
>98%
Specificity
95%
79-83%
96%
>95%
99%
Comments
• Non-invasive and inexpensive.
• Highly sensitive and specific before and after   
 treatment
• Highly sensitive but does not accurately 
 identify active infection 
• Not recommended after therapy
• Preferred test for confirming eradication 
• Not to be performed within 4 weeks of 
 antibiotic therapy
• Performed in clinic; variable availability
• Gold Standard. Detection is improved by using  
 special stains for e.g. the Warthin Starry silver  
 stain, or Giemsa staining
• Highly specific; poor sensitivity if adequate   
 transport media are not available 
• Expensive due to expertise and special culture  
 requirements, which may not be available 
• Rapid and cheap. Post-treatment sensitivity   
 reduced. 
Positive Predictive 
Value
84%
64%
88%
99%
Aga Khan University Hospital Clinical Laboratories offer H. pylori stool antigen, Anti-H. Pylori IgG and his-
topathology for diagnosis of this disease. However, there is a need to introduce rapid molecular tests for better 
diagnosis of H. pylori infection and antibiotic resistance.  
13
VOL. 43, ISSUE 1MARCH 2017
Screening for Neonatal Infections with 
TORCH Profile
Ms Nasreen Bano
Chemical Pathology
cytomegalovirus and toxoplasmosis (Table 1). 
A TORCH screen is typically performed when a 
woman shows symptoms of any of these diseases 
during pregnancy. 
The profile aids in the diagnosis of both congenital 
and acute acquired toxoplasmosis, cytomegalovirus, 
rubella and herpes simplex virus by testing IgM 
antibodies of all mentioned infections. The presence 
of IgM antibodies indicates acute or recent infection.
The TORCH profile is a group of tests used to 
screen newborns and, sometimes, pregnant women 
for certain infections that can cause birth defects 
in a baby if the mother contracts them during the 
pregnancy. The original concept of the TORCH 
perinatal infections was to group five infections 
with similar presentations, including rash and ocular 
findings A TORCH profile can detect numerous 
diseases, including herpes simplex, rubella, 
Table 1: Clinical manifestations of congenital infections 
Infection
Toxoplasmosis
Rubella Virus 
Infection
(German Measles)
Cytomegalo virus 
(CMV) Infection
Herpes Simplex virus 
(HSV) Infection
Clinical Manifestations suggestive of specific congenital infections in the neonate 
The most common finding is chorioretinitis
Hydrocephalus
Intellectual disability (mental retardation)
Intracranial calcifications (diffuse) 
Otherwise unexplained mononuclear CSF pleocytosis or elevated CSF protein
Classic triad of congenital toxoplasmosis consists of chorioretinitis, hydrocephalus, and intracranial 
calcifications
Hearing impairment(Sensorineural hearing loss)
Cataracts, congenital glaucoma, pigmentary retinopathy 
Cardiac defects (most commonly patent ductus arteriosus or peripheral pulmonary artery stenosis)
Radiolucent bone disease
Microcephaly
Hepatoslpenomegaly
Periventricular intracranial calcifications
Thrombocytopenia
Sensorineural hearing loss
Preterm born infants infected with CMV after birth (especially via breastmilk) can have cognitive and 
motor impairments later in life.
Most are asymptomatic at birth. 
Mucocutaneous vesicles or scarring
Elevated transaminases
Conjunctivitis or keratoconjunctiitis
CSF pleocytosis.
3 patterns of ~ equal frequency with symptoms between birth and 4wks:
Localized to the skin, eyes, mouth (SEM)
Localized CNS disease
Disseminated disease (present earliest)
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Bone marrow is the primary site of haemopoiesis 
throughout the life of an individual. A variety 
of infections can involve bone marrow however 
response of the bone marrow to infection is highly 
variable, depending on presence of co-existing 
disease, the age of the patient, nature (bacterial, 
viral, parasitic or fungal) and duration of the 
infection. In this article blood and bone marrow 
changes in viral infections will be discussed.
Viral infections are usually associated with 
lymphocytosis that sometimes exhibit atypical 
features (Figure. 1). Infectious mononucleosis 
caused by the Epstein-Barr virus (EBV) 
infection is characterized by the production of 
large numbers of atypical lymphocytes. These 
lymphocytes are characteristically pleomorphic, 
have abundant basophilic cytoplasm and 
prominent nucleoli. The similar picture may 
also be a feature of other viral infections like 
Cytomegalovirus (CMV) and hepatitis A as well 
as toxoplasmosis and some hypersensitivity 
reactions to drugs. In contrast, viruses that cause 
lymphocytosis without significant atypical features 
include Coxsackie virus, various adenoviruses 
and Human immunodeficiency virus (HIV). 
Haemoglobin concentration may be reduced 
due to bone marrow suppression, haemorrhage 
or haemolysis; conversely it may sometimes 
be increased in patients with a severe capillary 
leak syndrome in certain viral infections. A wide 
range of viral haemorrhagic fevers are associated 
characteristically with thrombocytopenia primarily 
due to increased platelet consumption. Immune 
mechanism in causation of cytopenias is well-
known, as in infections with Rubella, EBV, and 
Chronic hepatitis C infections. 
In addition to the features mentioned above, bone 
marrow cytology in some infections particularly 
by herpes viruses reveals haemophagocytosis. 
In HIV-positive patients, Human Herpes Virus 
8 (HHV8) infection may cause multicentric 
Castleman’s disease. Another non-specific 
feature is reactive increase in T-lymphocytes 
and plasma cells. Bone marrow hypocellularity 
with suppression of one or more lineages may 
be seen in several viral infections including 
CMV, HHV8, EBV, and Dengue fever. Erythroid 
lineage may be hyperplastic with haemolysis 
as in infectious mononucleosis whereas; in 
parvovirus-induced pure red cell aplasia there 
are prominent, very large pro-erythroblasts with 
a striking lack of more mature cells. Rarely, in 
immunologically competent people, persistent 
infection can lead to chronic red cell aplasia. In 
cases where thrombocytopenia is due to increased 
platelet destruction, bone marrow shows normal 
or increased number of megakaryocytes. Rarely, 
platelets are visible in bone marrow macrophages. 
Bone marrow histology provides better assessment 
of cellularity as well as certain findings that may 
not be recognized on examination of aspirate. 
CMV infections may depict eosinophilic 
intranuclear inclusions, albeit rarely these 
inclusions are either present within granulomas 
or interspersed in between haemopoietic cells. 
In acute EBV infection, bone marrow may 
exhibit gelatinous transformation or a diffuse 
increase in reticulin. Reactive lymphoid nodules 
in viral infection may be seen fairly commonly. 
Examples include chronic hepatitis B, hepatitis 
C and HIV infections. Where available, the 
presence of various viruses can be confirmed 
by immunohistochemistry using monoclonal 
antibodies. Lastly, viruses have also been 
implicated in causing lymphoproliferative 
disorders;  chronic hepatitis C infection 
Blood and Bone Marrow Changes in Viral 
Infections
Dr Muhammad Shariq Shaikh
Haematology
Figure 1. Atypical Lymphocytes on Peripheral blood film (at 40x).
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can be complicated by the development of 
low grade B-cell lymphoma. Whereas, in 
patients with impaired immunity and X-linked 
lymphoproliferative disorder, EBV infection 
has been found associated with a spectrum 
of lymphoproliferative disorders, including 
lymphoma. 
The peripheral blood and bone marrow response 
to viral infections are largely non-specific and 
similar changes occur in many other conditions, 
including trauma, administration of growth factors, 
carcinoma, Hodgkin and non-Hodgkin lymphoma 
and autoimmune disorders such as systemic lupus 
erythematosus. Therefore, high index of suspicion 
along with careful morphologic examination of 
both bone marrow aspirate and trephine biopsy is 
required in patients with suspected viral infection.
Malaria
Dr Natasha Ali
Malaria is a parasitic infection transmitted through 
the bite of infected female Anopheles mosquito. 
It is a preventable and curable disease and many 
countries are involved in the malaria eradication 
programme. Sub-Saharan Africa has the highest 
burden of disease. In 2015, 90 percent of malarial 
infection and 92 percent of deaths related to 
malaria occurred here. In Pakistan, the malaria 
transmission period occurs post monsoon but 
sporadic cases occur throughout the year. 
Anopheles mosquitos are called “malaria vectors”. 
There are, in total five species of malaria that 
cause infection. Four of these cause infection 
in humans while one is responsible for zoonotic 
infection. These species are:
1. Plasmodium Falciparum: Found in tropical 
 and subtropical areas (e.g. Africa). P. 
 falciparum is responsible for complicated and 
 cerebral malaria. A parasitemia of more than 
 two percent requires red blood cell exchange 
 along with anti-malarials as part of treatment. 
 In the peripheral blood smear following forms 
 are seen routinely:
2. Plasmodium vivax: found mostly in Asia, 
 Latin America and few parts of Africa. It is 
 largely absent in West Africa where 
 individuals lack Duffy red blood cell 
 antigen – strong predictor of p.vivax red cell 
 invasion. Based on its distribution, it is 
 the most prevalent human malarial parasite. 
 Glucose-6-phosphate dehydrogenase 
 deficiency is associated with protection and 
 decreased parasite density in p.vivax 
 infections. P.vivax has a very strong 
 predilection to infect reticulocytes. It can 
 become latent in the liver, the stage known as 
 hypnozoites responsible for causing relapses 
 after months or years from the infection. The 
 stages commonly seen in peripheral smear are:
Trophozoites: thin delicate rings 
in blood
Gametocyte showing presence of 
“Laveran’s bib”
Trophozoite (p.vivax)
Gametocyte (p.vivax)
Schizont (p.vivax)
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 and humans, scientists at Osaka University 
 in Japan have discovered strains of p.malariae 
 in chimpanzees from Africa. Despite being 
 infected, the chimps have not shown 
 symptoms of disease. The stages identified on 
 peripheral blood smear include:
5. Plasmodium Knowlesi: Traditionally was 
 regarded as a rare disease, occurring 
 sporadically in humans. However, recent 
 findings of a large number of infected patients 
 in Malaysian Borneo; reports of human cases 
 in Thailand, Myanmar, the Philippines, 
 Singapore; and few reports of p. knowlesi 
 malaria in travelers to the Malaysian Borneo 
 suggest that p. knowlesi may be more 
 widespread among humans than perceived. 
 The infection occurs in long-tailed and pig-
 tailed macaques that are present in forested 
 areas of Southeast Asia. P. knowlesi can be 
 transmitted from monkeys to humans by the 
 bite of an infected mosquito. In the blood 
 smear, the parasite is identified by:
The widely distributed malaria species causing 
infection in Pakistan include p.falciparum and 
p.vivax. Epidemiologically, Pakistan is classified 
as a moderate malaria endemic country. P.vivax is 
the major parasite species responsible for causing 
more than 80 percent of the confirmed, reported 
cases in the country.
3. Plasmodium ovale: Distributed primarily  
 throughout Sub-Saharan Africa. It has 
 also been reported from various islands of 
 Western Pacific. The diagnosis is based on its 
 characteristics on blood film and 
 differentiation from p.vivax. As p.vivax, 
 p.ovale also has a hypnozoite stage where the 
 parasites become suspended for many months. 
 After the sporozoites are introduced through 
 the bite of infected mosquitoes, these forms 
 invade the liver and within a single 
 parenchymal cell, the parasite matures within 
 ten days. Eventually, hundreds of merozoites 
 are produced which invade reticulocytes and 
 initiate the erythrocytic cycle. In the blood 
 smear, following stages are observed:
4. Plasmodium malariae: Infections caused 
 by p.malariae coincide with those caused 
 by p.falciparum. It is widely distributed in 
 Sub-Saharan Africa, Southeast Asia and 
 islands of Western Pacific. Cases have also 
 been reported in the Amazon basin of 
 South America. Not just limited to mosquitoes 
Schizont (p.ovale)
Trophozoite (p.malariae) – 
“Basket form”
Schizonts (p.knowlesi)
Gametocyte (p.malariae) – rosette 
pattern
Trophozoites (p.knowlesi)
Trophozoite (p.ovale)Gametocyte (p.ovale)
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Film Array Multiplex PCR: A Syndromic 
Diagnostic Approach
Dr Mohammad Zeeshan
Clinical Microbiology
Introduction
Early and reliable diagnosis of infectious diseases 
is increasingly challenging due to changing 
epidemiology in underlying diseases and use of 
drugs affecting the immune system. Therefore, 
throughout the globe, a paradigm shift has been 
observed from conventional time-consuming, 
laborious, and observer dependent tests towards 
molecular diagnostics. 
The role of microbiological evidence in infectious 
disease diagnosis is vital in initiating the 
appropriate antimicrobials, deciding patients’ 
prognoses, infection control and prevention 
strategies, and duration of hospital stay. 
Conventional tests such as microscopy and culture 
for bacteria and fungus have limitations due to 
low microbial count and longer incubation time. 
Limited viral testing in routine clinical laboratory 
often leads to under-diagnosis. Sometimes 
chemical analysis of sample (e.g. CSF) is not 
always reliable in delineating the causative agents, 
rendering inconclusive especially after the use of 
antibiotics.   
Moreover, diversity of causative agents creates 
a predicament for physicians due to overlapping 
clinical findings. They face a dilemma of deciding 
which test to order since a single diagnostic 
platform is not usually available for a particular 
presentation. This results in under diagnosis of 
infections and compromised patient care.
A solution to this problem is molecular syndromic 
diagnostic approach which uses broad test menu 
on a small amount of a single sample. Film Array, 
an FDA-cleared multiplex PCR system, is one 
such platform approved for clinical use. 
Principle
Multiplex PCR is a molecular biology technique 
in which more than one target sequence can be 
amplified by using multiple primer pairs in a 
reaction mixture. The system is designed to be 
used with comprehensive panels for different 
syndromes. Each panel offers testing for sets 
of  causative organisms including bacteria, 
viruses, yeast, parasites and/or antimicrobial 
resistant genes in one go, with turnaround time 
of a little over an hour. The following panels are 
available which include the most common clinical 
challenges these days:
l Meningitis \ Encephalitis Panel (ME): For 14 
 most relevant ME-associated pathogens, 
 including bacteria, viruses and a yeast (See 
 Table).
l Respiratory Panel: For a panel of 17 viruses 
 most commonly implicated in both upper and 
 lower respiratory tract infections, and three 
 bacteria which cannot be recovered on 
 routine culture: Bordetella pertussis, 
 Mycoplasma pneumoniae and Chlamydophila 
 pneumoniae.
l Blood Culture Identification Panel: For 
 a comprehensive list of 24 pathogens and 
 three antibiotic resistance genes associated  
 with bloodstream infections. 
l Gastrointestinal Panel: tests for 22 common 
 gastrointestinal pathogens including viruses, 
 bacteria and protozoa that cause infectious 
 diarrhea. 
 
The Clinical Laboratory of Aga Khan University 
Hospital microbiology section plans to introduce the 
Meningitis and Encephalitis panel (MEP) on Film 
Array based testing of CSF samples for patients 
with suspected meningitis and/or encephalitis. 
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How it works
The film-array 
reagent pouch 
stores all the 
necessary 
reagents used 
in sample 
preparation, 
reverse 
transcription 
and 
amplification. 
The hydrating 
solution and 
sample are added to the pouch which is then 
loaded into the film array machine. The results 
are analysed automatically and displayed on the 
monitor as soon as the run is completed in the 
form of a list of all the organisms “detected” and 
“not detected” in the panel. 
Advantages
1. It has high sensitivity and specificity for each 
 of the organisms tested in the panel. 
2. No precise measurement or pipetting, 
 therefore, no extensive hands-on technical 
 training is required in the entire procedure; its 
 use in Point of Care Testing (POCT) is   
 increasing.
3. Rapid identification of microorganism in one- 
 go with turn-around-time of one hour. 
4. It is a closed system, minimizing chances of 
 contamination. 
5. Although its one-time cost is high, rapidity 
 and reliability of test leads to shorter hospital  
 stay and lessen unnecessary procedures, 
 demonstrating its overall cost-effectiveness. 
6. Identification of targeted organisms also 
 minimizes the use of inappropriate antibiotics 
 and other drugs, preventing emergence of 
 antimicrobial resistance and aiding 
 antimicrobial stewardship.
Meningitis\Encephalitis
Sample type
Sample volume
Hands-on time
Run time 
Yeast:
— Cryptococcus   
 neoformans/gattii
Viruses:
— Cytomegalovirus (CMV)
— Enterovirus 
— Herpes simplex virus 1 (HSV-1) 
— Herpes simplex virus 2 (HSV-2) 
— Human Herpes virus 6 (HHV-6) 
— Human Parecho virus
— Varicella zoster virus (VZV)
Bacteria:
— Escherichia coli K1
— Haemophilus influenzae
— Listeria monocytogenes
— Neisseria meningitidis
— Streptococcus agalactiae
— Streptococcus 
 pneumoniae
CSF
200 µl
2 minutes
1 hour
M
 I 
C
 R
 O
 O
 R
 G
 A
 N
 I 
S 
M
 S
19
VOL. 43, ISSUE 1MARCH 2017
AKUH. In comparison to PCR, MLPA amplifies 
multiple genes in one run. Additionally MLPA 
can detect carrier status of inherited disease. 
Dr Salman Kirmani, Associate Professor, Chair 
Department of Pediatrics and Child Health 
discussed the importance of chromosomal 
microarray for diagnosing rare disorders. He 
explained that using this latest technology, it 
is now possible for smaller and more complex 
chromosome defects to be identified. Dr Kirmani 
explained that this technology is able to identify 
numerical abnormality however it cannot detect 
structural defects or anomalies easily.
 
Dr Lena Jafri, Assistant Professor Consultant 
Chemical Pathologist at AKUH emphasized 
the importance of College of American 
Pathologists (CAP) proficiency testing surveys 
as an educational and learning tool in her talk 
‘Competency Based Educational Challenges 
of Biochemical Genetics Laboratory’. She 
discussed few cases from CAP surveys and 
highlighted its importance in reliability and 
validity of patient reporting. ‘Inherited Metabolic 
Disorders In Pakistan-reaching the unreached’ 
was an interesting talk by Dr Bushra Afroze, 
Consultant Pediatrician & Clinical Geneticist at 
AKUH, who specializes in treating IMD. She 
introduced the audience to her new venture of 
tele health clinic between two clinical locations 
in two different cities of the country. With real 
life cases she explained how from a distance she 
has been managing patients with rare diseases. 
She emphasized that a strong liaison between 
clinicians in a country like Pakistan with limited 
World Rare Disease Day
Dr Lena Jafri
Section of Chemical Pathology
Karachi, Mar 10, 2017:  ‘CME Seminar on 
World Rare Disease Day’ was jointly organized 
by the Department of Pathology and Laboratory 
Medicine, Aga Khan University Hospital (AKUH) 
and Pakistan Society of Chemical Pathology 
(PSCP) at AKUH Karachi Pakistan. This CME 
seminar was arranged to mark the occasion 
of world rare disease day, which is observed 
worldwide on the last day of February each year. 
The objective was to create mass awareness about 
rare diseases and to ensure that patients with rare 
disease have access to treatment. We have been 
organizing this CME since the last two years. 
The theme for this year world rare disease day 
was research; with the slogan: ‘with 
research, possibilities are limitless!’. 
‘For most of the rare diseases, the 
reality is that the answers to most 
basic questions are missing. It is only 
through research that identification 
of previously unknown diseases and 
understanding of diseases evolve. 
Research leads to the development 
of new innovative treatments and in 
some cases a cure.’ said Dr Aysha 
Habib Khan, Associate Professor and 
Section Head, Chemical Pathology, AKUH while 
delivering the welcome address. She added that 
research is considered a key in bringing hope to 
the millions of people living with a rare disease 
across the world and their families. Dr Hafsa 
Majid Consultant Chemical Pathologist at AKUH 
gave an overview of rare diseases and highlighted 
the challenges faced in the diagnosis of these 
diseases in Pakistan. She shared the local data of 
Inherited Metabolic Diseases (IMD) diagnosed 
with locally available expertise at AKUH for 
organic acidurias & aminoacidopathies in high-
risk Pakistani pediatric population. During the past 
few years many rare diseases have been reported 
with further additions to this never ending list, 
explained Dr Majid. 
An enlightening talk on ‘Clinical Application of 
Multiplex Ligation-dependent Probe Amplification 
’ was given by Dr Zeeshan Ansar, Assistant 
Professor at the section of Molecular Pathology 
Panel of speakers in the question answer session at ‘CME Seminar World Rare Disease Day’
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Radiology Pathology Correlation
Dr Nasir Ud Din and Dr Dawar Khan
Histopathology and Radiology
A 15 year old boy presented with moderate localized 
nocturnal pain of right distal thigh which was 
relieved by aspirin. A plain radiograph showed an 
oval shape lytic lesion along the long axis of the 
bone surrounded by a thick dense rim of reactive 
sclerosis that fades imperceptibly into surrounding 
bone (Figure 1A). On lateral view, periosteal new 
bone formation is noted (Figure 1B). 
A biopsy is done and histological examination 
revealed neutrophilic abscess along with granulation 
tissue formation (Figure 2A,B). The final diagnosis 
after radiological-pathological correlation was 
Brodie abscess.
Discussion
A Brodie abscess is a subacute osteomyelitis which 
may persist for years before converting to a frank 
osteomyelitis. Classically, this may present after 
conversion as a draining abscess extending from 
the tibia out through the shin. Occasionally acute 
osteomyelitis may be contained to a localized area 
and walled off by fibrous and granulation tissue. This 
is termed as Brodie’s abscess.
Brodie’s abscess usually presents as a diagnostic 
dilemma and clinically mimics various benign and 
malignant conditions such as bone cyst, non-ossifying 
fibroma, osteoid osteoma, and Ewing sarcoma. Also, 
sometimes the radiological features are misleading. 
Typically these present in children, more frequently 
in boys. It usually occurs at the metaphysis of long 
bones, distal tibia, proximal tibia, distal femur, 
proximal or distal fibula, and distal radius. Most 
frequent causative organism is Staphylococcus 
aureus. Treatment is mainly surgery. If cavity is small 
then surgical evacuation & curettage is performed 
under antibiotic cover. If cavity is large then after 
evacuation, packing with cancellous bone chips.
Figure 1A,B. AP and Lateral view of distal femur shows lytic lesion 
posteriorly with sclerotic margins and thick periosteal reaction.
Figure 2A,B. Low and high power examination of biopsy showed sheets 
of neutrophils.
clinical expertise in IMD can be a pragmatic 
approach to provide services to more patients at 
their doorsteps.
Dr Farooq Ghani Associate Professor and 
Service Line Chief Department of Pathology 
and Laboratory Medicine in the closing remarks 
appreciated the team work of pathologists and 
pediatricians at AKUH in putting together this 
CME seminar and in helping the children and 
families with rare disease. We know that there is a 
dearth of awareness regarding these rare diseases 
and the need of the hour is to spread knowledge 
about them in order to prepare ourselves in such 
a way so that we can limit the dreadful effects of 
such diseases. This CME was an attempt in this 
regard with eminent speakers from Pathology & 
Pediatrics.
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Hepatitis C- Frequently asked Questions 
Sibtain Ahmed
Section of Clinical Chemistry
l Is it possible for someone to become infected 
 with HCV and then spontaneously clear the 
 infection?
 Yes. Approximately 15%–25% of persons clear 
 the virus from their bodies without treatment and 
 do not develop chronic infection; the reasons for 
 this are not well known.
l How likely is HCV infection to become 
 chronic?
 HCV infection becomes chronic in 
 approximately 75%–85% of cases.
l Can persons become infected with a different 
 strain of HCV after they have cleared the 
 initial infection?
 Yes. Prior infection with HCV does not protect 
 against later infection with the same or different 
 genotypes of the virus. This is because persons 
 infected with HCV typically have an ineffective 
 immune response due to changes in the virus 
 during infection. For the same reason, no 
 effective pre- or post-exposure prophylaxis (i.e., 
 immune globulin) is available.
l Is there a hepatitis C vaccine?
 No vaccine for hepatitis C is available. Research 
 into the development of a vaccine is under way
l How soon after exposure to HCV do 
 symptoms appear?
 In those persons who do develop symptoms, the 
 average time period from exposure to symptom 
 onset is 4–12 weeks (range: 2–24 weeks).
l How soon after exposure to HCV can anti-
 HCV be detected?
 HCV infection can be detected by anti-HCV 
 screening tests (enzyme immunoassay) 4–10 
 weeks after infection. Anti-HCV can be 
 detected in >97% of persons by 6 months after 
 exposure.
l How soon after exposure to HCV can HCV 
 RNA be detected by PCR?
 HCV RNA appears in blood and can be detected 
 as early as 2–3 weeks after infection.
l Under what circumstances is a false-positive 
 anti-HCV test result likely?
 False-positive anti-HCV tests appear more often 
 when persons at low risk for HCV infection (e.g., 
 blood donors) are tested. Therefore, it is 
 important to follow-up all positive anti-HCV 
 tests with a RNA test to establish current 
 infection.
l Under what circumstances might a false-
 negative anti-HCV test result occur?
 Persons with early HCV infection might not yet 
 have developed antibody levels high enough 
 that the test can measure. In addition, some 
 persons might lack the (immune) response  
 necessary for the test to work well. In these 
 persons, further testing such as PCR for HCV
 RNA may be considered.
l Can a patient have a normal liver enzyme  
 (e.g., ALT) level and still have chronic 
 hepatitis C?
 Yes. It is common for patients with chronic 
 hepatitis C to have liver enzyme levels that go 
 up and down, with periodic returns to normal or 
 near normal levels. Liver enzyme levels can  
 remain normal for over a year despite chronic 
 liver disease.
l Should HCV-infected persons be restricted 
 from working in certain occupations or 
 settings?
 CDC’s recommendations for prevention and 
 control of HCV infection specify that persons 
 should not be excluded from work, school, play, 
 child care, or other settings on the basis of their 
 HCV infection status. There is no evidence of 
 HCV transmission from food handlers, teachers, 
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 or other service providers in the absence of 
 blood-to-blood contact.
l Should a woman with HCV infection be 
 advised against breastfeeding?
 No. There is no evidence that breastfeeding 
 spreads HCV. However, HCV-positive mothers 
 should consider abstaining from breastfeeding if 
 their nipples are cracked or bleeding.
l When should children born to HCV-infected 
 mothers be tested to see if they were infected 
 at birth?
 Children should be tested for anti-HCV no 
 sooner than age 18 months because anti-HCV 
 from the mother might last until this age. If 
 diagnosis is desired before the child turns 18 
 months, testing for HCV RNA could be  
 performed at or after the infant’s first well-child 
 visit at age 1–2 months. HCV RNA testing 
 should then be repeated at a subsequent visit,  
 independent of the initial HCV RNA test result.
Reference:   CDC - Hepatitis C FAQs for Health Professionals; URL: 
https://www.cdc.gov/hepatitis/hcv/hcvfaq.htm )
Gentamicin
Vancomycin
Amikacin
Peak testing: 
Exactly 1 h after start 
of infusion of 3rd 
dose, or 1st dose in 
critically ill patients 
Trough: predose
Trough 
vancomycin 
concentrations are 
the most accurate and 
practical method to 
guide Vancomycin 
dosing. Serum trough 
concentrations should 
be obtained prior to 
the fourth or fifth dose
Peak: Exactly 1 h 
after start of infusion 
of 3rd dose, or 1st 
dose in critically ill 
patients) Trough: 
Predose
l Gentamicin is an antibiotic used to treat 
 life-threatening blood infections 
 caused by gram-negative bacilli, 
 particularly Citrobacter freundii , 
 Acinetobacter species, Enterobacter 
 species,  Escherichia coli, Klebsiella 
 pneumoniae, Proteus mirabilis , 
 Providencia stuartii, Pseudomonas 
 aeruginsa, and Serratia species.
l Gentamicin levels are tested for 
 monitoring adequacy of drug clearance 
 during gentamicin therapy
l Goal levels depend on the type of  
 infection being treated. 
l Vancomycin is an antibiotic used to treat 
 infections caused by gram-positive 
 organisms that are resistant to beta-
 lactam antibiotics, such as methicillin-
 resistant staphylococci (MRSA), 
 Staphylococcus viridans group, 
 penicillin/cephalosporin-resistant 
 Streptococcus pneumoniae, and 
 penicillin/ampicillin-resistant 
 Enterococcus species.
l Gentamicin levels are tested for 
 monitoring adequacy of drug 
 concentration during vancomycin 
 therapy
l Amikacin is an aminoglycoside used to 
 treat severe blood infections by 
 susceptible strains of gram-negative 
 bacteria.
l Amikacin levels are tested for 
 monitoring adequacy of blood 
 concentration during Amikacin therapy
Adults Multiple 
daily dose 
Peak: 4-10 ug/ml
Trough:  1-2 ug/ml
Adult Once daily 
dose 
Trough <1 ug/ml
Pediatrics trough 
conc.: <2ug/ml
Therapeutic 
concentration:
 >10 ug/ml
Trough:  15-20 ug/ml
Amikacin-Once 
daily dose
Trough: <1.0   ug/ml
Peak: 56-64  ug/ml
Amikacin-Multiple 
daily dose
Trough: 5-10   ug/ml
Peak: 15-30  ug/ml
l Dizziness
l Vertigo
l Ataxia 
l  Meniere   
 disease-like 
 syndrome
l Nephrotoxicity.
l Nephrotoxicity 
l Ototoxicity
l Ototoxicity,
l Nephrotoxicity
Details Of Therapeutic Drug Monitoring Of Antibiotics
Drug Toxicity Signs and 
Symptoms
Time of Sample 
Collection
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